We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BOQ:ASXBank of Queensland Limited Analysis

Data as of 2026-08-01 - not real-time

A$6.64

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Bank of Queensland is trading at AUD 6.64, edging close to its short‑term resistance of around AUD 6.69 while technical gauges show mixed signals. The 20‑day SMA sits above the 50‑day SMA, hinting at short‑term momentum, yet the price remains below the 200‑day SMA, indicating a longer‑term lag. Momentum is high, with an RSI of 69 and a bullish MACD histogram, but the stock is also in an overbought zone and volume is climbing, suggesting a potential short‑term pull‑back. Fundamentally, the bank carries a very high PE ratio of 44 versus an industry average of 18, a modest 2% revenue growth rate, and a low ROE of 1.6%, all pointing to limited growth prospects.
On the dividend side, the yield is attractive at about 6%, but the payout ratio exceeds 250%, raising serious sustainability concerns. The balance sheet shows substantial net debt, while the price‑to‑book ratio of 0.74 places the share below book value, offering a value cushion. Analyst sentiment is bearish (underperform) with target prices below the current level, and the market sentiment is extremely greedy, which could exacerbate short‑term volatility.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI in overbought territory
  • Price near technical resistance
  • Unsustainable dividend payout ratio

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Attractive dividend yield despite sustainability risk
  • Price below book value offering a margin of safety
  • Low beta indicating limited market volatility

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Stable regional banking franchise
  • Potential for balance‑sheet deleveraging
  • Moderate growth prospects and low long‑term volatility

Key Metrics & Analysis

Financial Health

Revenue Growth2.00%
Profit Margin5.89%
P/E Ratio44.3
ROE1.64%
ROA0.10%
P/B Ratio0.7
Op. Cash FlowA$2.0B
Industry P/E18.0

Technical Analysis

TrendNeutral
RSI69.1
SupportA$6.15
ResistanceA$6.69
MA 20A$6.39
MA 50A$6.30
MA 200A$6.63
MACDBullish
VolumeIncreasing
Fear & Greed Index92.88

Valuation

Fair ValueA$11.89
Target PriceA$6.27
Upside/Downside-5.58%
GradeFair
TypeValue
Dividend Yield6.02%

Risk Assessment

Beta0.40
Volatility14.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.